Studies on the mechanism of cell growth of ATL cells
ATL细胞生长机制的研究
基本信息
- 批准号:06404040
- 负责人:
- 金额:$ 16.9万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (A)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Summary of our studies on the mechanism of neoplastic cell growth in vivo of ATL cells are as follows. 1.We established a model of in vivo cell proliferation of ATL cells using SCID mice. 2.Fresh leukemic cells from ATL patients and HTLV-I-infected cell lines derived from leukemic cell clones showed tumorigenicity. HTLV-I-infected cell lines of nonleukemic cell origin and tax-transfected in vitro immortalized cells did not show tumorigenicity. 3.It appears that HTLV-I-expression is not needed for the cell growth of ATL cells in vivo and IL-2 autocrine mechanism in not involved in the cell growth in vivo. 4.We demonstrated the organ infiltration pattern of ATL cells in vivo using the radiolabeled anti-Tac antibody as a tracer. 5.We developed two monoclonal antibodies (MoAb) which block the unknown adhesion pathway between ATL cells and human umbilical vein endothelial cells (HUVEC). After characterizing the antigen, we succeeded in the cloning of its cDNA.The Agrecognized by the MoAb was found to be human OX40 homologue, a member of TNF receptor family. We then, for the first time, demonstrated that OX40 and its ligand (gp34) directly mediated the adhesion between ATL cells and HUVEC.Furthermore, we demonstrated the expression of gp34 on other vascular endothelial cells. OX40/gp34 may play a key role not only in the neoplastic cell growth and organ infiltration of ATL cells but also in the interaction between activated T cells and vascular endothelial cells which leads to infalmmatory lesions.
我们对ATL细胞体内肿瘤细胞生长机制的研究总结如下。1.建立了ATL细胞在SCID小鼠体内增殖的模型。2.来自ATL患者的新鲜白血病细胞和来自白血病细胞克隆的HTLV-I感染的细胞系显示出致瘤性。非白血病细胞来源的HTLV-I感染细胞系和紫杉醇转染的体外永生化细胞未显示致瘤性。3.ATL细胞在体内的生长不需要HTLV-1的表达,IL-2的自分泌机制不参与ATL细胞的体内生长。4.用放射性标记的抗Tac抗体作为示踪剂,在体内观察了ATL细胞的器官浸润模式。5.我们研制了两种单克隆抗体(MoAb),它们阻断了ATL细胞与人脐静脉内皮细胞(HUVEC)之间的未知粘附途径。经鉴定,成功克隆了该抗原的cDNA,其识别的抗原为TNF受体家族成员之一的人OX 40同源物。我们首次证实了OX 40及其配体(gp 34)直接介导ATL细胞与HUVEC的粘附,并证实了gp 34在其他血管内皮细胞上的表达。OX 40/gp 34不仅在ATL细胞的肿瘤细胞生长和器官浸润中起关键作用,而且在活化的T细胞和血管内皮细胞之间的相互作用中起关键作用,从而导致炎症性病变。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takashi Uchiyama et al.: "Pathophysiology of adult T cell leukemia cells-cell glowth characteristics-" Adult T cell leukemia(ed.by K.Takatsuki). 181-203 (1994)
Takashi Uchiyama 等人:“成人 T 细胞白血病细胞的病理生理学 - 细胞发光特征 -” 成人 T 细胞白血病(K.Takatsuki 编辑)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Uchiyama T.: "Pathophysiology of adult T cell leukemia cells : cell growth characteristics" "Adult T cell leukemia" oxford University Press. 181-203 (1994)
Uchiyama T.:“成人T细胞白血病细胞的病理生理学:细胞生长特征”“成人T细胞白血病”牛津大学出版社。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Akifuji Takaori-Kondo et al.: "Detection of homing,proliferation and iufiltration sites of adult T cell leukemia cells in severe combined immunodetiaency mice using radio." Jpn.J.Concer Res.(in press). (1995)
Akifuji Takaori-Kondo 等人:“使用无线电检测严重联合免疫缺陷小鼠中成人 T 细胞白血病细胞的归巢、增殖和渗透位点。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Imada K.: "Tumorigenicity of HTLV-I infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo" Blood. 86. 2350-2357 (1995)
Imada K.:“HTLV-I 感染细胞系在严重联合免疫缺陷小鼠中的致瘤性以及体内细胞增殖的特征”血液。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hosono M.: "Radiommunodetection of human leukemia with anti-interleukin-2 receptor antibody in severe combined immunodeficiency mice" Nuclear Medicine and Biology. 22. 869-874 (1995)
Hosono M.:“在严重联合免疫缺陷小鼠中使用抗白细胞介素 2 受体抗体对人类白血病进行放射免疫检测”核医学和生物学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UCHIYAMA Takashi其他文献
Water Sources of Lake Bottom Springs in Lake Kawaguchi, Northern Foot of Mount Fuji, Japan
日本富士山北麓河口湖湖底泉水源
- DOI:
10.5026/jgeography.129.665 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
YAMAMOTO Shinya;NAKAMURA Takashi;SERISAWA Yukihiko;NAKAMURA Seiji;YASUDA Taisuke;UCHIYAMA Takashi - 通讯作者:
UCHIYAMA Takashi
UCHIYAMA Takashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UCHIYAMA Takashi', 18)}}的其他基金
Study of a cooling time reduction method for cryogenic laser interferometric gravitational wave detectors
低温激光干涉引力波探测器冷却时间缩短方法研究
- 批准号:
22740148 - 财政年份:2010
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Immunotherapy of hematological melignancies based on activation of innate immunity and costimulation through OX40/OX40L
基于 OX40/OX40L 激活先天免疫和共刺激的血液恶性肿瘤的免疫治疗
- 批准号:
14207041 - 财政年份:2002
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Research for the volcanic activity of Fuji Volcano, based on the tephrostratigraphy of lake sediments from Lake Yamanaka, central Japan
基于日本中部山中湖沉积物的地层学研究富士火山的火山活动
- 批准号:
13480121 - 财政年份:2001
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel therapies of hematologic malignancies based on the functional modulation of the OX40/gp34 system
基于OX40/gp34系统功能调节的血液恶性肿瘤新疗法的开发
- 批准号:
12357005 - 财政年份:2000
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Analysis of signal transduction of OX40/gp34 and its role in pathogenesis of hematologic diseases
OX40/gp34信号转导及其在血液病发病中的作用分析
- 批准号:
10307023 - 财政年份:1998
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Basic Research for AIDS control A02 ; Pathophysiology and immunology of HIV-1 infection
艾滋病控制基础研究A02;
- 批准号:
10180102 - 财政年份:1998
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
ROLR OF OX40 IN IN VIVO CELL GROWTH AND ORGAN INFILTRATION OF ATL CELLS
OX40在ATL细胞体内细胞生长和器官浸润中的作用
- 批准号:
08457277 - 财政年份:1996
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study of T cell activation mechanism
T细胞激活机制研究
- 批准号:
62480262 - 财政年份:1987
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
The function of interleukin-2 and its receptor in B cell growth and differentiation
IL-2及其受体在B细胞生长和分化中的作用
- 批准号:
60570559 - 财政年份:1985
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Study on the protective factors for total mortality among HTLV-I carriers
HTLV-I携带者总死亡率的保护因素研究
- 批准号:
20K10506 - 财政年份:2020
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of a non-human primate model using cynomolgus monkeys for evaluating anti-HTLV-I mother to child infection drugs.
食蟹猴非人灵长类动物模型的建立,用于评价抗HTLV-I母婴感染药物。
- 批准号:
16K15285 - 财政年份:2016
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
HTLV-I Tax 和 HBZ 如何控制端粒酶活性以诱导成人 T 细胞白血病
- 批准号:
9513500 - 财政年份:2016
- 资助金额:
$ 16.9万 - 项目类别:
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
HTLV-I Tax 和 HBZ 如何控制端粒酶活性以诱导成人 T 细胞白血病
- 批准号:
9304181 - 财政年份:2016
- 资助金额:
$ 16.9万 - 项目类别:
Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir
HTLV-I Tax诱导的NF-kB在ICN1激活和vir永生化中的作用
- 批准号:
8435077 - 财政年份:2013
- 资助金额:
$ 16.9万 - 项目类别:
Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir
HTLV-I Tax诱导的NF-kB在ICN1激活和vir永生化中的作用
- 批准号:
8606171 - 财政年份:2013
- 资助金额:
$ 16.9万 - 项目类别:
Elucidation of mechanism for HTLV-I-associated Sjogren's syndrome
阐明 HTLV-I 相关干燥综合征的机制
- 批准号:
25461477 - 财政年份:2013
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The elucidation of the signalings of cytoskeletal reorganization involved in the development of HTLV-I-associated myelopathy
阐明参与 HTLV-I 相关脊髓病发生的细胞骨架重组信号
- 批准号:
24591267 - 财政年份:2012
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of HTLV-I-specific anti-cancer therapy by using single chain T cell receptors and single chain trimers of MHC-I.
利用单链T细胞受体和MHC-I单链三聚体开发HTLV-I特异性抗癌疗法。
- 批准号:
24590547 - 财政年份:2012
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mathematical epidemic models for the rapidly growing infection of HTLV-I
HTLV-I 感染迅速增长的数学流行病模型
- 批准号:
24540137 - 财政年份:2012
- 资助金额:
$ 16.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)